glp 1 in the brain GLP-1 Analogues Neurobiology of Addiction: Translational Insights and Therapeutic Perspectives Mechanisms of glucagon-like-peptide 1 in
Description
Galgani JE, Greenway FL, Caglayan S, Wong ML, Licinio J, Ravussin E
In contrast, GLP-1 alternatives build a long-term foundation for better health through natural GLP-1 activation
Novo Nordisk, the Danish pharma company behind several GLP-1RA drugs (including Ozempic/Wegovy and Saxenda) grew its sales by over 30% in 2023, and its share price rose by over 70% in the last year, making it the most valuable European company by market capitalization
Lancet 381 , 117124 (2013)
